Please login to the form below
KemPharm
This page shows the latest KemPharm news and features for those working in and with pharma, biotech and healthcare.
FDA panel backs Pfizer and Teva abuse-resistant painkillers
Last month the same panel also rejected an abuse-deterrent claim for KemPharm's Apadaz (benzhydrocodone hydrochloride and acetaminophen) whilst backing approval of the drug.
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Salary TBC
- Medical Writer/ Senior Medical Writer opportunities – Macclesfie...
-
competitive salary and benefits package
Subscribe to our email news alerts
- Pharma Brand Planners’ Blog (Part 2)
- The social dilemma: is it time for pharma to join the party?
- GCI Health continues to go from strength to strength, with significant new hires
- Sanofi/Regeneron’s Dupixent successor underwhelms in phase 2
- Faced with regulator’s merger concerns, BMS want to offload Otezla
- MIT reveals new pill to deliver insulin
PMHub
JPA Health Communications
JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...
Latest intelligence
- The social dilemma: is it time for pharma to join the party?
- Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...
- MIT reveals new pill to deliver insulin
- A new MIT research project, sponsored by Novo Nordisk, is aiming to deliver insulin orally with a pill that releases medicine in the stomach lining. Dina Patel interviews the team...
- 25 Women Leaders in UK Healthcare
- Women trailblazers helping to shape the future of healthcare (Part 1)...
Quick links
Infographics
